Article Listing - CHMP recommends approval of Atripla for HIV-1

BOOTS TO COPROMOTE W-L'S LOPID

10 February 1992

Boots Co has announced that its wholly-owned US subsidiary, Boots Pharmaceuticals Inc, has commenced the copromotion of Warner-Lambert subsidiary Parke-Davis'...

NEW YORK MEETINGS

10 February 1992

Two industry-related meetings are due to be held soon at the Loews Summit Hotel, New York: Cost Containment and Quality...

NEW FORMULATION OF JANSSEN'S NIZORAL

10 February 1992

Janssen Pharmaceutical has launched a new unperfumed, less viscous formulation of its Nizoral (ketoconazole) shampoo in the UK. Nizoral, Janssen...

FEMALE CONDOM RECOMMENDED FOR USA

10 February 1992

The Obstetrics and Gynec-ology Devices Advisory Commit-tee of the US Food and Drug Administration has recommended approval of Chartex Inter-national's...

SPAIN LOOKING TO GENERICS

10 February 1992

The full incorporation of Spain into the European Community, which takes effect on October 7, means that the country will...

EC "BLOW" TO NEW OTC PRODUCTS

10 February 1992

As it now stands, the Commission of the European Communities' proposed directive on advertising of over-the counter products in the...

INDUSTRY RESPONSE TO JAPAN DRUG PRICE MOVES

10 February 1992

The Koseisho, Japan's Ministry of Health and Welfare, is in the process of clarifying how it intends to implement the...

"KEY" US PATENT FOR BIOPURE'S HEMOPURE

10 February 1992

Boston, Massachusetts-based start-up company Biopure Corp reports that it has received a US patent covering its novel blood substitute Hemopure,...

STOCK MARKET COMMENTARY: EUROPE

10 February 1992

EUROPE: saw most stock markets down by the end of the reporting period, with FRANKFURT doing marg-inally better. Among the...

GOOD YEAR FOR SANOFI IN 1991

10 February 1992

In 1991 sales at the French health and beauty concern, Elf Sanofi, increased 5.8% to 19.6 billion French francs ($3.6...

Showing 94841-94850 of 95345 articles